Ligand validation:3QXV

MTX: METHOTREXATE

MTX is a Ligand Of Interest in 3QXV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3QXV_MTX_D_2000	58%	14%	0.139	0.919	1.83	2.01	4	12	2	0	100%	1
3QXV_MTX_A_2000	51%	14%	0.156	0.91	1.91	1.93	5	12	5	0	100%	1
3QXV_MTX_E_2000	36%	16%	0.195	0.886	1.94	1.79	5	10	0	0	100%	1
3QXV_MTX_B_2000	27%	17%	0.19	0.839	1.82	1.83	5	10	0	0	100%	1
3QXV_MTX_C_2000	23%	13%	0.156	0.843	1.71	2.23	3	9	2	0	64%	0.6364
3QXT_MTX_A_2000	64%	9%	0.102	0.901	2.19	2.23	10	18	1	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	1	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	2	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	1	0	100%	1
1DDR_MTX_B_200	93%	2%	0.077	0.971	2.29	4.49	7	20	0	1	100%	1
3IA4_MTX_A_164	91%	17%	0.077	0.962	1.84	1.8	3	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.